Annual Report 2018

Report this content

Respiratorius presents Annual Report 2018

Lund April 30, 2019d

The Board

Johan Drott

President Respiratorius AB

+46 709-22 41 40

Respiratorius AB (publ) is developing drug candidates with the goal to launch drugs for common diseases cancer, chronic obstructive pulmonary disease (COPD) and severe asthma. In addition, the project portfolio is a project for improved diagnosis of certain cardiovascular diseases.



Documents & Links